Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 378,862 shares at $6.39 ($2.4M) on 2025-11-26, disclosed to the SEC on 2025-12-01.
Scheduled sale ($2.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.39 | 127,938 | $818K | 33.7% |
| 2 | $6.39 | 127,938 | $818K | 33.7% |
| 3 | $6.44 | 61,493 | $396K | 16.3% |
| 4 | $6.44 | 61,493 | $396K | 16.3% |
| Total | $6.41 avg | 378,862 | $2.4M | 100% |
| Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |
| VIR | SELL | 2023-02-17 | $1.0M | — | Filing → |